Clustering data with hclust algorithm for (Study ST003972)

None (Direct infusion) POSITIVE ION MODE (Analysis AN006539)
MetaboliteStructureF1F2
Docosahexaenoic acidME10494310.791.21
LPE P-18:1ME10494050.861.14
SM 18:1;O2/25:0ME10493610.851.15
Octadecadienoic acidME10494260.841.16
Eicosatrienoic acidME10494290.841.16
Lauric acidME10494190.841.16
CAR 20:1ME10494170.881.12
Eicosatetraenoic acidME10494280.881.12
SM 18:1;O2/26:1ME10493620.901.10
Hexadecenoic acidME10494230.901.10
LPE P-18:0ME10494060.901.10
LPE P-16:0ME10494020.911.09
SM 18:1;O2/25:1ME10493600.911.09
SM 18:1;O2/15:0ME10493441.130.87
SM 18:1;O2/14:0ME10493431.100.90
LPC O-16:0ME10493971.110.88
LPC O-18:0ME10493991.110.89
SM 18:1;O2/22:0ME10493551.060.94
Pentadecylic acidME10494221.060.94
CAR 16:0ME10494141.060.94
CE 20:5ME10494391.060.94
CE 14:0ME10494331.050.95
SM 18:1;O2/16:0ME10493461.050.95
LPE 20:4ME10494111.090.91
SM 18:1;O2/16:1ME10493451.080.92
PC 14:0/16:1ME10493631.080.92
CAR 18:0ME10494161.080.92
Margaric acidME10494251.080.92
PC P-16:0/18:1, P-18:1/16:0ME10493700.931.07
PC 18:0/22:6ME10493940.931.07
PC 16:0/22:6, 18:2/20:4ME10493870.931.07
Octadecenoic acidME10494270.931.07
Heptadecenoic acidME10494240.931.07
Eicosenoic acidME10494300.931.07
CAR 22:1ME10494180.931.07
Docosatetraenoic acidME10494320.931.07
SM 18:1;O2/23:0ME10493570.941.06
CE 18:2ME10494360.941.06
LPE 20:1ME10494130.941.06
SM 18:1;O2/24:1ME10493580.951.05
PC P-16:0/18:0, P-18:0/16:0, O-18:1/16:0, O-16:0/18:1ME10493710.951.05
LPE 19:0ME10494100.951.05
PC 18:1/22:6, 18:2/22:5ME10493930.951.05
PC 18:1/18:2, 16:0/20:3ME10493810.971.03
PC 18:0/18:2, 18:1/18:1ME10493820.971.03
LPE 20:3ME10494120.971.03
LPE 18:1ME10494080.971.03
LPE 18:0ME10494090.971.03
CE 20:3ME10494410.971.03
CE 16:1ME10494340.971.03
CE 18:1ME10494370.971.03
SM 18:1;O2/23:1ME10493560.961.04
PC P-16:0/16:0, O-16:0/16:1ME10493650.961.04
CE 22:6ME10494440.961.04
PC 18:0/20:3ME10493900.961.04
PC 18:0/20:1, P-18:1/22:6ME10493921.040.96
PC P-18:0/20:0, P-16:0/22:0ME10493861.030.97
PC O-18:0/18:1, P-18:0/18:0ME10493781.030.97
CE 23:5ME10494451.030.97
LPC 16:0ME10493981.030.97
PC 18:0/20:2, P-18:2/22:6ME10493911.020.98
PC 14:0/16:0ME10493641.020.98
LPC 18:0ME10494011.020.98
Myristic acidME10494211.020.98
SM 18:1;O2/22:1ME10493541.001.00
SM 18:1;O2/18:1ME10493481.001.00
PC O-16:0/20:0ME10493791.001.00
PC 18:0/22:4, 20:0/20:4, 20:2/20:2ME10493961.001.00
CE 20:1ME10494421.001.00
CE 20:0ME10494431.001.00
CAR 18:1ME10494151.001.00
CE 19:1ME10494381.001.00
Tridecylic acidME10494201.010.99
SM 18:1;O2/24:0ME10493591.010.99
SM 18:1;O2/20:1ME10493521.010.99
SM 18:1;O2/19:1ME10493501.010.99
SM 18:1;O2/19:0ME10493511.010.99
SM 18:1;O2/17:0ME10493471.010.99
PC P-18:0/20:1, P-16:0/22:1ME10493851.010.99
PC P-18:0/18:1, P-18:1/18:0ME10493771.010.99
PC 18:0/18:0ME10493841.010.99
LPE 18:2ME10494071.010.99
PC 16:0/18:2ME10493741.010.99
SM 18:1;O2/18:0ME10493490.991.01
PC O-16:0/16:0ME10493660.991.01
PC 18:0/22:5ME10493950.991.01
PC 16:1/18:2ME10493730.991.01
PC 16:1/16:1, 14:1/18:1ME10493670.991.01
PC 16:0/18:1ME10493750.991.01
LPE 16:0ME10494040.991.01
LPC 18:1ME10494000.991.01
CE 16:0ME10494350.991.01
CE 20:4ME10494400.991.01
SM 18:1;O2/20:0ME10493530.981.02
PC O-16:0/18:0ME10493720.981.02
PC 18:2/20:2, 18:0/20:4ME10493890.981.02
PC 18:2/18:2, 16:0/20:4ME10493800.981.02
PC 18:1/20:4, 16:0/22:5ME10493880.981.02
PC 18:0/18:1ME10493830.981.02
PC 16:1/16:0, 14:1/18:0ME10493680.981.02
PC 16:0/18:0ME10493760.981.02
LPE 16:1ME10494030.981.02
PC 16:0/16:0ME10493690.981.02

Factors:

F1Sample source:human brain | genotype:E3/3
F2Sample source:human brain | genotype:E4/4
Data matrix
  logo